Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy
- PMID: 28062504
- DOI: 10.1161/ATVBAHA.116.308253
Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy
Abstract
Objective: Pulmonary embolism (PE) is a life-threatening manifestation of venous thromboembolism with a high recurrence rate after anticoagulation cessation. Recently, we have reported that prothrombotic clot phenotype in venous thromboembolism patients is associated with an increased risk of recurrent deep-vein thrombosis.
Approach and results: We tested whether abnormal clot properties are predictive of recurrent PE. We investigated 156 consecutive white patients aged 18 to 65 years after the first-ever provoked or unprovoked PE (n=89), with or without deep-vein thrombosis. Plasma fibrin clot permeability (Ks), turbidity measurements, calibrated automated thrombography, and efficiency of fibrinolysis using clot lysis time, maximum D-dimer levels, and rate of increase in D-dimer levels were evaluated at ≥3 months of anticoagulant therapy, at least 4 weeks since the anticoagulation withdrawal. The primary end point was recurrent PE during a median follow-up of 50 months. Recurrent PE was diagnosed in 23 (14.7%; 5%/yr) patients. Recurrent PE was associated with formation of denser fibrin networks reflected by lower Ks (P=0.007) and impaired fibrinolysis, as evidenced by prolonged clot lysis time (P=0.012) and reduced maximum rate of increase in D-dimer levels in the lysis assay (P=0.004). Patients with recurrent PE had higher plasma D-dimer (P<0.001) and thrombin peak (P=0.007) compared with the remainder, whereas turbidity measurements and maximum D-dimer levels did not differ in the recurrence. Multivariate model showed that independent predictors of recurrent PE were female sex, unprovoked venous thromboembolism, higher plasma D-dimer, reduced Ks, and reduced maximum rate of increase in D-dimer levels in the lysis assay (all P<0.05).
Conclusions: Altered fibrin clot properties including formation of more compact clots displaying impaired susceptibility to lysis may predispose to recurrent PE.
Keywords: fibrin; fibrinolysis; pulmonary embolism; recurrence; thrombosis.
© 2016 American Heart Association, Inc.
Similar articles
-
Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.Thromb Haemost. 2017 Aug 30;117(9):1739-1749. doi: 10.1160/TH17-01-0060. Epub 2017 Aug 3. Thromb Haemost. 2017. PMID: 28771277
-
Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.J Thromb Haemost. 2019 Nov;17(11):1912-1922. doi: 10.1111/jth.14579. Epub 2019 Aug 8. J Thromb Haemost. 2019. PMID: 31323706
-
Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.Thromb Haemost. 2014 Aug;112(2):287-96. doi: 10.1160/TH13-11-0980. Epub 2014 Mar 20. Thromb Haemost. 2014. PMID: 24652596
-
Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.Thromb Haemost. 2015 Jun;113(6):1210-5. doi: 10.1160/TH14-04-0396. Epub 2014 Aug 14. Thromb Haemost. 2015. PMID: 25119194 Review.
-
Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants.Int Angiol. 2017 Oct;36(5):395-401. doi: 10.23736/S0392-9590.16.03785-8. Epub 2016 Dec 16. Int Angiol. 2017. PMID: 27982558 Review.
Cited by
-
Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism.Sci Rep. 2019 Jan 11;9(1):72. doi: 10.1038/s41598-018-37114-4. Sci Rep. 2019. PMID: 30635605 Free PMC article.
-
Acetaldehyde exposure alters fibrin polymerization, fibrinolysis, and fibrin network structure in vitro.Res Pract Thromb Haemost. 2025 Jun 6;9(4):102921. doi: 10.1016/j.rpth.2025.102921. eCollection 2025 May. Res Pract Thromb Haemost. 2025. PMID: 40678355 Free PMC article.
-
Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis.J Thromb Haemost. 2022 May;20(5):1158-1165. doi: 10.1111/jth.15661. Epub 2022 Feb 13. J Thromb Haemost. 2022. PMID: 35108438 Free PMC article.
-
Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study.J Thromb Thrombolysis. 2019 Nov;48(4):603-609. doi: 10.1007/s11239-019-01914-w. J Thromb Thrombolysis. 2019. PMID: 31432450 Free PMC article.
-
Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach.Circulation. 2024 Sep 10;150(11):884-898. doi: 10.1161/CIRCULATIONAHA.124.069728. Epub 2024 Sep 9. Circulation. 2024. PMID: 39250537 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical